<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMM</journal-id><journal-title-group><journal-title>Open Journal of Medical Microbiology</journal-title></journal-title-group><issn pub-type="epub">2165-3372</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmm.2022.123009</article-id><article-id pub-id-type="publisher-id">OJMM-119914</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Consistency Analysis of Detection Results of Two Herpes Simplex Virus (HSV) Type II Nucleic Acid Detection Kits
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Weihua</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>Gong</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xinping</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Hainan Tropical Oncology Institute, Haikou, China</addr-line></aff><aff id="aff2"><addr-line>School of Pharmacy, Hainan University, Haikou, China</addr-line></aff><aff id="aff1"><addr-line>Laboratory Department of Hainan Cancer Hospital, Haikou, China</addr-line></aff><pub-date pub-type="epub"><day>12</day><month>08</month><year>2022</year></pub-date><volume>12</volume><issue>03</issue><fpage>96</fpage><lpage>100</lpage><history><date date-type="received"><day>16,</day>	<month>August</month>	<year>2022</year></date><date date-type="rev-recd"><day>17,</day>	<month>September</month>	<year>2022</year>	</date><date date-type="accepted"><day>20,</day>	<month>September</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Objective: </b>
  The objective of the study is to verify the clinical validity of the following kits with the comparative experimental analysis and evaluate whether their performance can meet the clinical requirements, i.e. Class III in vitro diagnostic reagent “Herpes Simplex Virus (HSV) Type II Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method)” of Daan Gene Co., Ltd
  . 
  (Daan kit for short)
   
  and “Herpes Simplex Virus (HSV) Type II Nucleic Acid Detection Kit (Fluorescence PCR Method)” of Wuhan Biot Gene Co., Ltd
  . 
  (Biot kit for short). <b>Method:</b> In the study process, the samples were divided into positive and negative groups according to the control test results, and the clinical application performance of Daan kit and Biot kit was evaluated by comparing their test results. <b>Results:</b> The results show that two kits indicate the same test results, i.e. 26 positive and 107 negative samples in a total of 133 male urethral discharge samples, and 32 positive and 238 negative samples in a total of 270 female cervical secretion samples. <b>Conclusion:</b> It can be concluded from the clinical test that Daan and Biot Herpes Simplex Virus (HSV) Type II Nuc
  - 
  leic Acid Test Kits are reliable, accurate, safe, convenient for use, stable and high-value in the clinical application.
 
</p></abstract><kwd-group><kwd>Herpes Simplex Virus (HSV) Type II</kwd><kwd> Nucleic Acid Detection Kits</kwd><kwd> Consistency Analysis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Herpes simplex virus (HSV) is categorized to α subfamily of the Herpesviridae, and its virus size is about 180 nm. This kind of virus can be classified as type I (HSV-I) and type II (HSV-II) based on differences in antigenicity. HSV-II can cause the cutaneous herpes below the waist and external genital herpes [<xref ref-type="bibr" rid="scirp.119914-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.119914-ref2">2</xref>], mainly in cervixes, vaginas, vulvar skins of women and penises and urethras of men. It is regarded as the main pathogenesis for the genital inflammation and herpes [<xref ref-type="bibr" rid="scirp.119914-ref3">3</xref>]. Herpes simplex virus (HSV) is widespread in the population, with humans being the only host and patients and carriers being the only source of infection [<xref ref-type="bibr" rid="scirp.119914-ref4">4</xref>]. HSV-II is mainly transmitted by the sexual intercourse [<xref ref-type="bibr" rid="scirp.119914-ref5">5</xref>]. It is relatively difficult to prevent such disease due to the widespread presence of carriers and occult infections, as well as the many modes of transmission and the absence of a reliable vaccine [<xref ref-type="bibr" rid="scirp.119914-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.119914-ref7">7</xref>]. Therefore, the development of diagnostic techniques that allow a rapid detection of HSV-II is of great importance for the auxiliary diagnosis of HSV-II infection, the efficacy of antiviral therapy and epidemiological studies. This technique is PCR fluorescence probe method. PCR assay has high sensitivity and specificity in detecting HSV, which is recommended by European laboratories and US Centers for Disease Control and Prevention (CDC) [<xref ref-type="bibr" rid="scirp.119914-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.119914-ref9">9</xref>].</p><p>In recent years, HSV-II detection kits based on fluorescence PCR and PCR-fluorescence probe method have been used more frequently in China. Zhao Zhao et al. adopted the fluorescence PCR to conduct HSV-II nucleic acid detection in 2230 patients with suspected urogenital tract herpes in Zhejiang Provincial People’s Hospital from 2008 to 2017, and they found 557 HSV-II positive patients, accounting for 24.98% [<xref ref-type="bibr" rid="scirp.119914-ref10">10</xref>]. Yu Xueying et al. adopted PCR-fluorescence probe method to detect HSV-I/II in 488 patients attending the STD Clinic of Guangdong Provincial Dermatology Hospital, and they found 136 HSV-II positive and 6 HSV-I positive patients, accounting for 29.89% [<xref ref-type="bibr" rid="scirp.119914-ref11">11</xref>].</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Samples</title><p>Clinically confirmed or suspected HSV-II infection cases were enrolled in this study, and there were total 403 samples, including 133 male urethral discharge samples and 270 female cervical secretion samples.</p></sec><sec id="s2_2"><title>2.2. Reagents and Instruments</title><p>1) Daan Herpes Simplex Virus (HSV) Type II Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method) and Biot Herpes Simplex Virus (HSV) Type II Nucleic Acid Detection Kit (Fluorescence PCR Method). DNA of all samples was extracted and detected by fluorescent PCR with two reagents, and the results were compared.</p><p>2) Extraction, amplification, and other experimental conditions are same for both reagents.</p></sec><sec id="s2_3"><title>2.3. Statistical Processing</title><p>The statistics of the test results are mainly collated with fourfold tables. The test results of two reagents were undergone the Kappa identity test and a P-value less than or equal to 0.01 would be considered statistically significant for the difference tested.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The samples of 133 males urethral discharge (study objects) were divided into positive and negative groups according to the control test results. When comparing the test results obtained with Daan and Biot kits, it was found that they all indicated 26 positive and 107 negative samples. The test results were consistent (<xref ref-type="table" rid="table1">Table 1</xref>), which was statistically significant (<xref ref-type="table" rid="table2">Table 2</xref>). The samples of 270 females cervical secretion (study objects) were divided into positive and negative groups according to the control test results. When comparing the test results obtained with Daan and Biot kits, it was found that they all indicated 32 positive and 238 negative samples. The test results were consistent (<xref ref-type="table" rid="table3">Table 3</xref>), which was statistically significant (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>According to the literature, an estimated 500 million people worldwide have genital infections with HSV-I or HSV-II, of which 90% of the pathogens of genital</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Result comparison of male urethral discharge samples with two test kits</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Test</th><th align="center" valign="middle"  colspan="2"  >Biot reagent</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Daan reagent</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >26</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >107</td><td align="center" valign="middle" >107</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Total</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >107</td><td align="center" valign="middle" >133</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Symmetric measures analysis of male urethral discharge samples with two test kits</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Value</th><th align="center" valign="middle" >Asymp. Std. Error<sup>a</sup></th><th align="center" valign="middle" >Approx. T<sup>b</sup></th><th align="center" valign="middle" >Approx.Sig.</th></tr></thead><tr><td align="center" valign="middle" >Measure of Agreement Kappa N of Valid Cases</td><td align="center" valign="middle" >1.000 133</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >11.533</td><td align="center" valign="middle" >0.000</td></tr></tbody></table></table-wrap><p><sup>a</sup>Not assuming the null hypothesis. <sup>b</sup>Using the asymptotic standard error assuming the null hypothesis.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Result comparison of female cervical secretion samples with two test kits</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Test</th><th align="center" valign="middle"  colspan="2"  >Biot reagent</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Daan reagent</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >32</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >238</td><td align="center" valign="middle" >238</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Total</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >238</td><td align="center" valign="middle" >270</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Symmetric measures analysis of female cervical secretion samples with two test kits</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Value</th><th align="center" valign="middle" >Asymp. Std. Error<sup>a</sup></th><th align="center" valign="middle" >Approx. T<sup>b</sup></th><th align="center" valign="middle" >Approx. Sig.</th></tr></thead><tr><td align="center" valign="middle" >Measure of Agreement Kappa N of Valid Cases</td><td align="center" valign="middle" >1.000 270</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >16.432</td><td align="center" valign="middle" >0.000</td></tr></tbody></table></table-wrap><p><sup>a</sup>Not assuming the null hypothesis. <sup>b</sup>Using the asymptotic standard error assuming the null hypothesis.</p><p>herpes are HSV-II and only 10% are HSV-I [<xref ref-type="bibr" rid="scirp.119914-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.119914-ref13">13</xref>]. The incidence in China is also increasing year by year. Therefore, the early selection of appropriate laboratory diagnostic methods is important to reduce the infectiousness and pathogenicity of HSV. The current laboratory diagnostic methods of HSV-II mainly include the microscopic observation, cell culture, serological tests and PCR assay of nucleic acid detection [<xref ref-type="bibr" rid="scirp.119914-ref14">14</xref>]. For the high sensitivity and specificity, the PCR assay is recommended in detecting HSV. In recent years, HSV-II detection kits based on fluorescence PCR and PCR-fluorescence probe method have been used more frequently in China. However, the clinical effectiveness evaluation of HSV-II in vitro diagnostic kits produced by different companies in China has not yet been studied in a comparative test.</p><p>For 403 samples in this test, there were a total of 133 male urethral discharge samples. The positive and negative coincidence rate, as well as the total coincidence rate of Daan and Biot reagents were all 100%. Kappa identity test indicated that the results of Daan and Biot reagents in detecting human urogenital tract secretions were in good consistency (kappa = 1, P &lt; 0.001), and of statistical significance. For 270 female cervical secretion samples, the positive and negative coincidence rate, as well as the total coincidence rate of Daan and Biot reagents were all 100%. Kappa identity test indicated that the results of Daan and Biot reagents in detecting human urogenital tract secretions were in good consistency (kappa = 1, P &lt; 0.001), and of statistical significance.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The test results indicate that “Herpes Simplex Virus (HSV) Type II Nucleic Acid Detection Kit (PCR-Fluorescence Probe Method)” of Daan Gene Co., Ltd. and “Herpes Simplex Virus (HSV) Type II Nucleic Acid Detection Kit (Fluorescence PCR Method)” of Wuhan Biot Gene Co., Ltd. are reliable, accurate, safe, convenient for use, stable and high-value in the clinical application.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Xu, W.H., Gong, W. and Chen, X.P. (2022) Consistency Analysis of Detection Results of Two Herpes Simplex Virus (HSV) Type II Nucleic Acid Detection Kits. Open Journal of Medical Microbiology, 12, 96-100. https://doi.org/10.4236/ojmm.2022.123009</p></sec></body><back><ref-list><title>References</title><ref id="scirp.119914-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y.L., Shi, X.P., Wei, J.B., et al. (2021) Clinical Significance of Genotyping Detection of Genital Herpes Simplex Virus. Chinese Journal of AIDS &amp; STD, 27, 3.</mixed-citation></ref><ref id="scirp.119914-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Lyu, J.X. and Chen, X.D. (2015) Test and Diagnosis of Venereology and Dermatology. 2nd Edition, People’s Medical Publishing House, Beijing.</mixed-citation></ref><ref id="scirp.119914-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Liu, W., Luo, X.H., Xiang, Y., et al. (2018) Study on a Real-Time Fluorescence Quantitative PCR Assay to Detect Herpes Simplex Virus (HSV) Type II. Genomics and Applied Biology, 37, 5.</mixed-citation></ref><ref id="scirp.119914-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Fatahzadeh, M. and Schwartz, R.A. (2007) Human Herpes Simplex Virus Infections: Epidemiology, Pathogenesis, Symptomatology, Diagnosis, and Management. Journal of the American Academy of Dermatology, 57, 737-763. https://doi.org/10.1016/j.jaad.2007.06.027</mixed-citation></ref><ref id="scirp.119914-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Wald, A., Zeh, J., Selke, S., et al. (2000) Reactivation of Genital Herpes Simplex Virus Type 2 Infection in Asymptomatic Seropositive Persons. New England Journal of Medicine, 342, 844-850. https://doi.org/10.1056/NEJM200003233421203</mixed-citation></ref><ref id="scirp.119914-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Heilingloh, C.S., Lull, C., Kleiser, E., et al. (2020) Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies than Herpes Simplex Virus Type 1. MDPI AG, 3, 478.</mixed-citation></ref><ref id="scirp.119914-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Stanfield, B.A., Kousoulas, K.G., Agustin, F. and Edward, G. (2021) Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Viruses, 13, 1637. https://doi.org/10.3390/v13081637</mixed-citation></ref><ref id="scirp.119914-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Patel, R., Kennedy, O.J., Clarke, E., Geretti, A., Nilsen, A., Lautenschlager, S., Green, J., Donders, G., van der Meijden, W., Gomberg, M., Moi, H. and Foley, E. (2017) 2017 European Guidelines for the Management of Genital Herpes. International Journal of STD &amp; AIDS, 28, 1366-1379. https://doi.org/10.1177/0956462417727194</mixed-citation></ref><ref id="scirp.119914-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Workowski, K.A. (2015) Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 61, S759-S762. https://doi.org/10.1093/cid/civ771</mixed-citation></ref><ref id="scirp.119914-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ge, Y.M., Ye, C.M., Dong, X.Y. and Zhao, Z. (2021) Detection and Analysis of Herpes Simplex Virus Type II Infection in 2008-2017 by Fluorescence PCR. Chinese Journal of Health Laboratory Technology, 31, 1-3+9.</mixed-citation></ref><ref id="scirp.119914-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Yu, X.Y., Chen, D.X., Wu, X.Z., Fang, M.H., Huang, J.M., Xue, Y.H. and Zheng, H.P. (2021) Analysis of Herpes Simplex Virus Infection by Nucleic Acid Test of 488 Patients in STD Clinic in Guangzhou. The Journal of Practical Medicine, 37, 1878- 1882.</mixed-citation></ref><ref id="scirp.119914-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">James, C., Harfouche, M., Welton, N.J., Turner, K.M., Abu-Raddad, L.J., Gottlieb, S.L. and Looker, K.J. (2020) Herpes Simplex Virus: Global Infection Prevalence and Incidence Estimates, 2016. Bulletin of the World Health Organization, 98, 315-329. https://doi.org/10.2471/BLT.19.237149</mixed-citation></ref><ref id="scirp.119914-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Cengiz, L., Cengiz, A.T., K&amp;#305;yan, M., U&amp;#287;urel, &amp;Scaron;. and Aksoy, M.M. (2019) Clinical Diagnosis, Treatment and Prevention in Herpes Simplex Virus (HSV) Infection. European Journal of Therapeutics, 2, 245-253.</mixed-citation></ref><ref id="scirp.119914-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Anderson, N.W., Buchan, B.W. and Ledeboer, N.A. (2014) Light Microscopy, Culture, Molecular, and Serologic Methods for Detection of Herpes Simplex Virus. Journal of Clinical Microbiology, 52, 2-8. https://doi.org/10.1128/JCM.01966-13</mixed-citation></ref></ref-list></back></article>